The DNA damage checkpoint is activated during residual tumour cell survival to methotrexate treatment as an initial step of acquired drug resistance

  1. De Anta, J.M.
  2. Pérez-Castro, A.J.
  3. Freire, R.
  4. Mayol, X.
Aldizkaria:
Anti-Cancer Drugs

ISSN: 0959-4973

Argitalpen urtea: 2006

Alea: 17

Zenbakia: 10

Orrialdeak: 1171-1177

Mota: Artikulua

DOI: 10.1097/01.CAD.0000236311.73703.D2 GOOGLE SCHOLAR
Datuen iturria: Scopus